EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

What’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis

Ezequiel J Zaidel, Sol C Song iD, Juan J Sterba iD, Agustina Piccinato, María Candelaria Ramos, Silvina L Cacia

Therapeutic Advances in Cardiovascular Disease · 2024

DOI: 10.1177/17539447241295957 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2024. Verfasst von Ezequiel J Zaidel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Buenos Aires, Buenos Aires,…. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies, Exercise. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Awareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardiac amyloidosis and also review lifestyle, including current challenges and opportunities for specific dietary concerns and exercise sports for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialCardiomyopathiesExerciseHumansTreatment OutcomeExercise TherapyRisk Reduction BehaviorCardiovascular AgentsGenetic Predisposition to DiseasePrealbumin

Stichwörter der Autor:innen

cardiac amyloidosiscardiomyopathydisease-modifying agentsheart failuresmall interfering RNA

Substanzen

TTR protein, humanCardiovascular AgentsPrealbumin

Autor:innen und Institutionen

  • Cardiovascular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
  • Department of Pharmacology and Toxicology, Faculty of Medicine, University of Buenos Aires, Paraguay 2110, 15th Floor, Buenos Aires C1121A6B, Argentina.

ORCID-Profile: Sol C Song, Juan J Sterba

Zitieren

APA

Zaidel, E. J., Song, S. C., Sterba, J. J., Piccinato, A., Ramos, M. C., & Cacia, S. L. (2024). What’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447241295957

Vancouver

Zaidel EJ, Song SC, Sterba JJ, Piccinato A, Ramos MC, Cacia SL. What’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis. Therapeutic Advances in Cardiovascular Disease. 2024. doi:10.1177/17539447241295957

BibTeX
@article{Zaidel2024,
  author = {Zaidel, Ezequiel J and Song, Sol C and Sterba, Juan J and Piccinato, Agustina and Ramos, María Candelaria and Cacia, Silvina L},
  title = {What’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2024},
  doi = {10.1177/17539447241295957}
}
Kostenlos starten →